change postal 2 share the pain resolution

It underscores the Administration’s firm commitment to protecting the American people and holding accountable those who commit health care fraud,” said James M. “Today’s multi-billion dollar settlement is unprecedented in both size and scope.

The civil settlement resolves claims relating to Paxil, Wellbutrin and Avandia, as well as additional drugs, and also resolves pricing fraud allegations. GSK will also pay $2 billion to resolve its civil liabilities with the federal government under the False Claims Act, as well as the states. GSK’s guilty plea and sentence is not final until accepted by the U.S. The criminal plea agreement also includes certain non-monetary compliance commitments and certifications by GSK’s U.S. Under the terms of the plea agreement, GSK will pay a total of $1 billion, including a criminal fine of $956,814,400 and forfeiture in the amount of $43,185,600. GSK agreed to plead guilty to a three-count criminal information, including two counts of introducing misbranded drugs, Paxil and Wellbutrin, into interstate commerce and one count of failing to report safety data about the drug Avandia to the Food and Drug Administration (FDA). history and the largest payment ever by a drug company. The resolution is the largest health care fraud settlement in U.S. Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the Justice Department announced today.

Change postal 2 share the pain resolution